Indications for pelvic lymphadenectomy in prostate cancer.

[1]  A. Pantuck,et al.  Review of staging modalities in clinically localized prostate cancer. , 1999, Urology.

[2]  W. Catalona,et al.  Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer. , 1999, The Journal of urology.

[3]  A. Partin,et al.  Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients , 1999, Cancer.

[4]  W. Pauer,et al.  Use of talcum in sclerotherapy of pelvic lymphoceles. , 1999, Techniques in urology.

[5]  J. Petros,et al.  Evaluation of staging lymphadenectomy in prostate cancer. , 1998, Urology.

[6]  G H Hinkle,et al.  Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium‐111 capromab pendetide , 1998, Cancer.

[7]  M. Manyak,et al.  (111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY , 1998 .

[8]  Louis Glass,et al.  Lymphoceles: diagnosis and management in urologic patients. , 1998, Urology.

[9]  G. H. Weiss,et al.  Lymphoceles after laparoscopic pelvic node dissection. , 1998, Urology.

[10]  O. Halvorsen,et al.  Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer. , 1998, Scandinavian journal of urology and nephrology.

[11]  M. Steiner,et al.  Minilaparotomy staging pelvic lymphadenectomy follow-up: a safe alternative to standard and laparoscopic pelvic lymphadenectomy , 1998, World Journal of Urology.

[12]  A. Raboy,et al.  Extraperitoneal endoscopic pelvic lymph node dissection: a review of 125 patients. , 1997, The Journal of urology.

[13]  P. Unger,et al.  Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques. , 1997, The Journal of urology.

[14]  S. I. Cohen,et al.  Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer. , 1997, Journal of endourology.

[15]  P. Hanno,et al.  The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer. , 1997, British journal of urology.

[16]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[17]  S. Herrell,et al.  Staging pelvic lymphadenectomy for localized carcinoma of the prostate: a comparison of 3 surgical techniques. , 1997, The Journal of urology.

[18]  M. Borghi,et al.  [Correlation between computed axial tomography and ileum obturating lymphadenectomy in localized adenocarcinoma of the prostate]. , 1997, Archivos espanoles de urologia.

[19]  E. Cattolica,et al.  Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice. , 1997, Urology.

[20]  M. Fallick,et al.  Laparoscopic marsupialization of lymphocele after laparoscopic lymph node dissection. , 1996, Journal of endourology.

[21]  M. Kattan,et al.  The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer. , 1996, British journal of urology.

[22]  W. Brant,et al.  A new minimally invasive open pelvic lymphadenectomy surgical technique for the staging of prostate cancer. , 1996, Urology.

[23]  R. Kaufman,et al.  Mini-laparotomy pelvic lymph node dissection minimizes morbidity, hospitalization and cost of pelvic lymph node dissection. , 1996, The Journal of urology.

[24]  J. Cummings,et al.  Radical perineal prostatectomy without pelvic lymphadenectomy: selection criteria and early results. , 1996, The Journal of urology.

[25]  W. Hop,et al.  Eliminating the need for per-operative frozen section analysis of pelvic lymph nodes during radical prostatectomy. , 1995, British journal of urology.

[26]  H. Levin,et al.  Open pelvic lymph node dissection for prostate cancer: a reassessment. , 1995, Urology.

[27]  A. Tewari,et al.  The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. , 1995, Urology.

[28]  A. Diokno,et al.  Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? , 1995, British journal of urology.

[29]  Burgers Jk,et al.  Monoclonal antibody imaging of recurrent and metastatic prostate cancer. , 1995 .

[30]  Y. Arai,et al.  MINI‐LAPAROTOMY STAGING PELVIC LYMPH NODE DISSECTION FOR LOCALIZED PROSTATE CANCER , 1995, International journal of urology : official journal of the Japanese Urological Association.

[31]  J. Bishoff,et al.  Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. , 1995, Urology.

[32]  R. Babaian,et al.  Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356. , 1994, The Journal of urology.

[33]  V. Nicolas,et al.  MR-Tomographie des Prostatakarzinoms - Vergleich konventionelle und endorektale MRT , 1994 .

[34]  H. Ruckle,et al.  One hundred consecutive laparoscopic pelvic lymph node dissections: comparing complications of the first 50 cases to the second 50 cases. , 1994, Urology.

[35]  D. Bostwick,et al.  Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. , 1994, The Journal of urology.

[36]  D. Haraf,et al.  Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases. , 1994, The Journal of urology.

[37]  J. Cummings,et al.  Complications of laparoscopic urological surgery: experience at St. Louis University. , 1994, The Journal of urology.

[38]  W. Schuessler,et al.  Laparoscopic standard pelvic node dissection for carcinoma of the prostate: is it accurate? , 1993, The Journal of urology.

[39]  R. Clayman,et al.  Staging pelvic lymphadenectomy for prostate cancer: a comparison of laparoscopic and open techniques. , 1993, The Journal of urology.

[40]  D. Albala,et al.  Treatment of persistent lymphatic drainage after laparoscopic pelvic lymph node dissection and radical retropubic prostatectomy. , 1993, Journal of endourology.

[41]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[42]  F. Marshall,et al.  Mini-laparotomy staging pelvic lymphadenectomy (minilap). Alternative to standard and laparoscopic pelvic lymphadenectomy. , 1993, Urology.

[43]  J. Oesterling,et al.  Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. , 1993, Urology.

[44]  L R Kavoussi,et al.  Complications of laparoscopic pelvic lymph node dissection. , 1993, The Journal of urology.

[45]  Fenguangzhai Song.  CD , 1992 .

[46]  P. Scardino,et al.  Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.

[47]  W. Schuessler,et al.  Laparoscopic pelvic lymphadenectomy for prostatic adenocarcinoma. , 1992, The Urologic clinics of North America.

[48]  J. Boullier,et al.  Staging laparoscopic pelvic lymph node dissection: comparison of results with open pelvic lymphadenectomy. , 1992, The Journal of urology.

[49]  R. Stephenson,et al.  Prostate specific antigen in patients with clinical stage C prostate cancer: relation to lymph node status and grade. , 1991, The Journal of urology.

[50]  A. Rademaker,et al.  Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.

[51]  D. Johnson,et al.  Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. , 1990, Urology.

[52]  J. Oesterling,et al.  Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.

[53]  T. Stamey,et al.  Capsular Penetration in Prostate Cancer. Significance for Natural History and Treatment , 1990, The American journal of surgical pathology.

[54]  G. Williams,et al.  Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma. , 1990, Urology.

[55]  T. Stamey,et al.  Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.

[56]  R. Vessella,et al.  The value of serum prostate specific antigen determinations before and after radical prostatectomy. , 1989, The Journal of urology.

[57]  J. Oesterling,et al.  Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.

[58]  P. Elfving,et al.  Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma. , 1988, Scandinavian journal of urology and nephrology. Supplementum.

[59]  J. W. Segura,et al.  Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. , 1987, The Journal of urology.

[60]  J. Oesterling,et al.  Frozen section detection of lymph node metastases in prostatic carcinoma: accuracy in grossly uninvolved pelvic lymphadenectomy specimens. , 1986, The Journal of urology.

[61]  S. Loening,et al.  The frozen section in lymphadenectomy for carcinoma of the prostate. , 1984, The Journal of urology.

[62]  S. Loening,et al.  Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. , 1983, The Journal of urology.

[63]  J. R. Sharpe,et al.  Accuracy of frozen section diagnosis in pelvic lymph node staging biopsies for adenocarcinoma of the prostate. , 1983, The Journal of urology.

[64]  A. Sagalowsky,et al.  Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer. , 1982, The Journal of urology.

[65]  H. Zincke,et al.  Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. , 1982, The Journal of urology.

[66]  W. Catalona,et al.  Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. , 1982, The Journal of urology.

[67]  T. Stamey,et al.  Complication of 125 iodine implantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy. , 1981, The Journal of urology.

[68]  D. Mcleod,et al.  Radical prostatectomy with pelvic lymphadenectomy: observations on the accuracy of staging with lymph node frozen sections. , 1981, The Journal of urology.

[69]  W. Whitmore,et al.  Lymphocele after pelvic lymphadenectomy for urologic cancer. , 1981, Urology.

[70]  C. Brendler,et al.  Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. , 1980, The Journal of urology.

[71]  A. Wein,et al.  Staging pelvic lymphadenectomy for carcinoma of the prostate review of 91 cases. , 1980, The Journal of urology.

[72]  D. Skinner,et al.  Pelvic lymphadenectomy in the management of carcinoma of the prostate. , 1980, The Journal of urology.

[73]  C. Brendler,et al.  Experience with Gleason's histopathologic grading in prostatic cancer. , 1980, The Journal of urology.

[74]  H. Herr.  Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantation. , 1979, Urology.

[75]  J. Grayhack,et al.  Morbidity of pelvic lymphadenectomy. , 1979, Urology.

[76]  W. Whitmore,et al.  Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. , 1979, The Journal of urology.

[77]  F. Freiha,et al.  Surgical staging of prostatic cancer: transperitoneal versus extraperitoneal lymphadenectomy. , 1977, The Journal of urology.

[78]  R. Gittes,et al.  Morbidity of pelvic lymphadenectomy and radical prostatectomy for prostatic cancer. , 1977, The Journal of urology.

[79]  R. Gittes,et al.  Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. , 1976, The Journal of urology.

[80]  G. Dodd,et al.  Postoperative pelvic lymphocysts. , 1970, The American journal of roentgenology, radium therapy, and nuclear medicine.

[81]  G. Dodd,et al.  Lymphocysts; a complication of radical pelvic surgery. , 1959, American journal of obstetrics and gynecology.

[82]  N. Mori.  Clinical and experimental studies on the so-called lymphocyst which develops after radical hysterectomy in cancer of the uterine cervix. , 1955, Journal of the Japanese Obstetrical & Gynecological Society.